dimethyl fumarate accord
accord healthcare s.l.u. - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
elvanse adult hart hylki 30 mg
takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 30 mg
elvanse adult hart hylki 50 mg
takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 50 mg
elvanse adult hart hylki 70 mg
takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 70 mg
elvanse adult hart hylki 20 mg
takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 20 mg
elvanse adult hart hylki 40 mg
takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 40 mg
elvanse adult hart hylki 60 mg
takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 60 mg
natpar
takeda pharmaceuticals international ag ireland branch - skjaldkirtilshormón - hypoparateyroidism - kalsíumsterastasis - natpar er ætlað sem viðbótarmeðferð hjá fullorðnum sjúklingum með langvarandi ofsabjúgshjúp, sem ekki er hægt að stjórna með nægilegum hætti með venjulegri meðferð einu sér.
marcain adrenalin stungulyf, lausn 2,5 mg/ml+5 míkróg/m
aspen pharma trading limited - bupivacainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 2,5 mg/ml+5 míkróg/m
marcain adrenalin stungulyf, lausn 5 mg/ml+5 míkróg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 5 mg/ml+5 míkróg/ml